REGULATION 21 opportunity for the Player and/or the Player's representative to attend the B Sample opening and analysis in accordance with the International Standard for Laboratories if such analysis is requested; and (f) the Player's right to request copies of the A and B Sample laboratory documentation package which includes information as required by the International Standard for Laboratories. If World Rugby decides not to bring forward the Adverse Analytical Finding as an anti-doping rule violation, it shall so notify the Player, the Player’s Union, National Anti- Doping Organisation and WADA. 21.7.3.2 Where requested by the Player or World Rugby, arrangements shall be made to analyse the B Sample in accordance with the International Standard for Laboratories. A Player may accept the A Sample analytical results by waiving the requirement for B Sample analysis. World Rugby may nonetheless elect to proceed with the B Sample analysis. 21.7.3.3 The Player and/or his representative shall be allowed to be present at the analysis of the B Sample. Also, a representative of World Rugby as well as a representative of the Player's Union shall be allowed to be present. 21.7.3.4 If the B Sample analysis does not confirm the A Sample analysis, then (unless World Rugby takes the case forward as an anti-doping rule violation under Regulation 21.2.2) the entire test shall be considered negative and the Player, the Player’s Union, National Anti-Doping Organisation and WADA shall be so informed. 21.7.3.5 If the B Sample analysis confirms the A Sample analysis, the findings shall be reported to the Player, the Player’s Union, National Anti-Doping Organisation and WADA. 21.7.4 Review of Atypical Findings 21.7.4.1 As provided in the International Standard for Laboratories, in some circumstances laboratories are directed to report the presence of Prohibited Substances, which may also be produced endogenously, as Atypical Findings, i.e., as findings that are subject to further investigation. 21.7.4.2 Upon receipt of an Atypical Finding, World Rugby shall conduct a review to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions; (b) there is any apparent departure from the International Standard for Testing and Investigations or International Standard for Laboratories that caused the Atypical Finding; and/or (c) World Rugby is aware of any historical test data with respect to the Player which explains the Atypical Finding as arising from a permitted source. 21.7.4.3 If the review of an Atypical Finding under Regulation 21.7.4.2 reveals an applicable TUE and/or a departure from the International Standard for Testing and Investigations or the International Standard for Laboratories and/or historical test data that caused the Atypical Finding and/or explains the Atypical Finding as arising from a permitted source, the entire test Last update: 14 January, 2015 354
World Rugby Handbook
To see the actual publication please follow the link above